These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 38805550

  • 1. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.
    Catani JPP, Smet A, Ysenbaert T, Vuylsteke M, Bottu G, Mathys J, Botzki A, Cortes-Garcia G, Strugnell T, Gomila R, Hamberger J, Catalan J, Ustyugova IV, Farrell T, Stegalkina S, Ray S, LaRue L, Saelens X, Vogel TU.
    Elife; 2024 May 28; 12():. PubMed ID: 38805550
    [Abstract] [Full Text] [Related]

  • 2. Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.
    Perofsky AC, Huddleston J, Hansen CL, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Lewis N, Whittaker L, Ermetal B, Harvey R, Galiano M, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Sullivan SG, Barr IG, Subbarao K, Krammer F, Bedford T, Viboud C.
    Elife; 2024 Sep 25; 13():. PubMed ID: 39319780
    [Abstract] [Full Text] [Related]

  • 3. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L, Kays SK, Zimmer G, von Messling V.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654
    [Abstract] [Full Text] [Related]

  • 4. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
    Gao J, Couzens L, Burke DF, Wan H, Wilson P, Memoli MJ, Xu X, Harvey R, Wrammert J, Ahmed R, Taubenberger JK, Smith DJ, Fouchier RAM, Eichelberger MC.
    mBio; 2019 Apr 09; 10(2):. PubMed ID: 30967460
    [Abstract] [Full Text] [Related]

  • 5. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.
    Wan H, Gao J, Yang H, Yang S, Harvey R, Chen YQ, Zheng NY, Chang J, Carney PJ, Li X, Plant E, Jiang L, Couzens L, Wang C, Strohmeier S, Wu WW, Shen RF, Krammer F, Cipollo JF, Wilson PC, Stevens J, Wan XF, Eichelberger MC, Ye Z.
    Nat Microbiol; 2019 Dec 09; 4(12):2216-2225. PubMed ID: 31406333
    [Abstract] [Full Text] [Related]

  • 6. Evolution and Antigenic Advancement of N2 Neuraminidase of Swine Influenza A Viruses Circulating in the United States following Two Separate Introductions from Human Seasonal Viruses.
    Kaplan BS, Anderson TK, Chang J, Santos J, Perez D, Lewis N, Vincent AL.
    J Virol; 2021 Sep 27; 95(20):e0063221. PubMed ID: 34379513
    [Abstract] [Full Text] [Related]

  • 7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931689
    [Abstract] [Full Text] [Related]

  • 8. COBRA N2 NA vaccines induce protective immune responses against influenza viral infection.
    Zhang X, Skarlupka AL, Shi H, Ross TM.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2403175. PubMed ID: 39291424
    [Abstract] [Full Text] [Related]

  • 9. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD, Jang H, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2019 Feb 01; 93(3):. PubMed ID: 30429350
    [Abstract] [Full Text] [Related]

  • 10. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM, Allen JD, Bebin-Blackwell AG, Carter DM, Alefantis T, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978710
    [Abstract] [Full Text] [Related]

  • 11. Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model.
    Rosu ME, Kok A, Bestebroer TM, de Meulder D, Verveer EP, Pronk MR, Dekker LJM, Luider TM, Richard M, van den Brand JMA, Fouchier RAM, Herfst S.
    J Virol; 2022 Mar 23; 96(6):e0195921. PubMed ID: 35107371
    [Abstract] [Full Text] [Related]

  • 12. Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses.
    Uno N, Ebensen T, Guzman CA, Ross TM.
    J Virol; 2024 Sep 17; 98(9):e0035424. PubMed ID: 39171925
    [Abstract] [Full Text] [Related]

  • 13. Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.
    Tan J, O'Dell G, Hernandez MM, Sordillo EM, Kahn Z, Kriti D, van Bakel H, Ellebedy AH, Wilson PC, Simon V, Krammer F, McMahon M.
    J Virol; 2022 Jan 26; 96(2):e0142121. PubMed ID: 34669506
    [Abstract] [Full Text] [Related]

  • 14. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X, Ilyushina NA, Lugovtsev VY, Bovin NV, Couzens LK, Gao J, Donnelly RP, Eichelberger MC, Wan H.
    J Virol; 2017 Jan 15; 91(2):. PubMed ID: 27807224
    [Abstract] [Full Text] [Related]

  • 15. A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model.
    Strohmeier S, Amanat F, Zhu X, McMahon M, Deming ME, Pasetti MF, Neuzil KM, Wilson IA, Krammer F.
    mBio; 2021 Dec 21; 12(6):e0224121. PubMed ID: 34809451
    [Abstract] [Full Text] [Related]

  • 16. Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.
    Eshaghi A, Duvvuri VR, Li A, Patel SN, Bastien N, Li Y, Low DE, Gubbay JB.
    Influenza Other Respir Viruses; 2014 Mar 21; 8(2):250-7. PubMed ID: 24313991
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
    Allen JD, Ross TM.
    Front Immunol; 2021 Mar 21; 12():707339. PubMed ID: 34475872
    [Abstract] [Full Text] [Related]

  • 18. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM, Darby CA, Johnson SK, Carlock MA, Kirchenbaum GA, Allen JD, Vogel TU, Delagrave S, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978709
    [Abstract] [Full Text] [Related]

  • 19. Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.
    Rajão DS, Gauger PC, Anderson TK, Lewis NS, Abente EJ, Killian ML, Perez DR, Sutton TC, Zhang J, Vincent AL.
    J Virol; 2015 Nov 15; 89(22):11213-22. PubMed ID: 26311895
    [Abstract] [Full Text] [Related]

  • 20. Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.
    Kirkpatrick Roubidoux E, McMahon M, Carreño JM, Capuano C, Jiang K, Simon V, van Bakel H, Wilson P, Krammer F.
    mSphere; 2021 Feb 10; 6(1):. PubMed ID: 33568453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.